Search
Now showing items 1-1 of 1
A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes
Stadler, M et al. (2004)
Wissenschaftlicher Artikel